Crohn's disease and secondary amyloidosis: Early complication? A case report and review of the literature

Journal of Renal Care

Volumn 35, Issue 3, 2009, Pages 147-150

  Basturk, Taner ^a   Ozagari, Aysim ^b   Ozturk, Tulin ^a   Kusaslan, Ramazan ^a   Unsal, Abdulkadir ^a  

^a Department of Nephrology ^*  (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Crohn's disease; Renal failure; Secondary amyloidosis

Indexed keywords

COLCHICINE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AMYLOIDOSIS; ARTICLE; BIOPSY; BLOOD; CASE REPORT; CHRONIC KIDNEY FAILURE; CROHN DISEASE; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; MALE; PROTEINURIA; RARE DISEASE; RENAL REPLACEMENT THERAPY; RISK FACTOR; TIME;

ADULT; AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; COLCHICINE; CROHN DISEASE; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; HYPERTENSION; HYPOALBUMINEMIA; KIDNEY FAILURE, CHRONIC; MALE; MESALAMINE; PROTEINURIA; RARE DISEASES; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 69949149154     PISSN: 17556678     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2009.00106.x     Document Type: Article

References (31)

1. Bollée G., Guery B., Joly D. et al., (2008). Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clinical Journal of the American Society of Nephrology 3, 375-381.
2. Boscá M. M., Pérez-Baylach CM., Solis M. A. et al. (2006). Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor. Gut 55 (2), 294-295.
3. Botto M., Hawkins P. N., Bickerstaff M. C. et al. (1997). Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Medicine 3, 855-859.
4. Chugh K. S., Datta B. N., Singhal P. C et al. (1981). Pattern of renal amyloidosis in Indian patients. Postgraduate Medicine 57, 31-35.
5. Cooke W. T., Mallas E. &Prior P. (1980). Crohn's disease: course, treatment and long term prognosis. Quarterly Journal of Medicine 49, 363-384.
6. Falk R. H., Comenzo R. L. &Skinner M. (1997). The systemic amyloidoses. New England Journal of Medicine 337 (13), 898-909.
7. Fausa O., Nygaard K. & Elgjo K. (1977). Amyloidosis and Crohn's disease. Scandinavian Journal of Gastroenterology 12, 657-662.
8. Fernández-Castroagudin J., Brage-Varela A., Lens-Neo X. M. et al. (2002). Amiloidosis renal como manifestación clínica inicial de la enfermedad de Crohn. Gastroenterology and Hepatology 25, 395-397.
9. Gitkind M. J. &Wright S. C. (1990). Amyloidosis complicating inflammatory bowel disease. A case report and review of the literature. Digestive Diseases and Sciences 7, 906-908.
10. Glenner G. G. (1980). Amyloid deposits and amyloidosis. The b-fibrilloses. II. New England Journal of Medicine 302, 1333-1343.
11. Graether S. P., Young I. D. & Kisilevsky R. (1996). Early detection of inflammation-associated amyloid in murine spleen using thioflavin T fluorescence of tissue homogenates: implications for amyloidogenesis. Amyloid 3, 20-27.
12. Gratacos J., Orellana C., Sanmarti R. et al. (1997). Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. Journal of Rheumatology 24, 912-915.
13. Greenstein A. J., Janowitz H. D. & Sachar D. B. (1976). The extraintestinal complication of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55, 401-412.
14. Greenstein A. J., Sachar D. B., Panday A. K. N., et al. (1992). Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) 71, 261-270.
15. Horie Y., Chiba M., Miura K. et al. (1997). Crohn's disease associated with renal amyloidosis successfully treated with an elemental diet. Journal of Gastroenterology 32, 663-667.
16. Khan M.F. & Falk R.H. (2001). Amyloidosis. Postgraduate Medical Journal 77 (913), 686-693.
17. Kindy M. S. & Rader D. J. (1998). Reduction in amyloid A amyloid formation in apolipoprotein-E deficient mice. American Journal of Pathology 152, 1387-1395.
18. Kisilevsky R. & Boudreau L. (1983). Kinetics of amyloid deposition. I. The effects of amyloid enhancing factor and splenectomy. Laboratory Investigation 48, 53-59.
19. Lind E., Fausa O., Gjone E. et al. (1985). Crohn's disease. Treatment and outcome. Scandinavian Journal of Gastroenterology 20, 1014-1018.
20. Lovat L. B., Madhoo S., Pepys M. B. et al. (1997). Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease. Gastroenterology 112, 1362-1365.
21. Lowdell C. P., Shousha S. &Parkins R. A. (1986). The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients. Diseases of the Colon & Rectum 29, 351-354.
22. Marcus S. B., Brown J. B., Melin-Aldana H. et al. (2008). Tubulointerstitial nephritis: an extraintestinal manifestation of Crohn disease in children. Journal of Pediatric Gastroenterology and Nutrition 46, 338-341.
23. Meyers S. (1997). Systemic amyloidosis complicating inflammatory bowel disease. Gastroenterology 113, 731.
24. Palma C. L., Grunholz D. & Osorio G. (2005). Clinical features of patients with the pathological diagnosis of amyloidosis. Revista Medica de Chile 133 (6), 655-661.
25. Pardi D. S., Tremaine W. J., Sandborn W. J. et al. (1998). Renal and urologic complications of inflammatory bowel disease. American Journal of Gastroenterology 93, 504-514.
26. Rashid H., Blake D., Gokal R. et al. (1980). The association of renal amyloidosis with regional enteritis (Crohns'disease). Report of two cases and review of the literature. Clinical Nephrology 14, 154-157.
27. Ravid M., Shapira J., Kedar I. et al. (1979). Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration. Acta Hepato-gastroenterologica 26, 513-515.
28. Ravid M., Shapira J., Lang R. et al. (1982). Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis. Annals of the Rheumatic Diseases 41, 587-592.
29. Verbanck J., Lameire N., Praet M. et al. (1979). Renal amyloidosis as complication of Crohn's disease. Acta Clinica Belgica 34, 6-13.
30. Wester A. L., Vant M. H. & Fausa O. (2001). Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Inflammatory Bowel Diseases 7, 295-300.
31. Weterman I. T., Biemond I. & Pena A. S. (1990). Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut 31, 1387-1390.